FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel nucleoside monophosphate derivatives with residues of lipid esters of the general formula (I) where R1, R2 mean linear or branched saturated alkyl chain containing 1-20 carbon atoms; R3, R5 mean hydrogen atom, hydroxyl groups; R4 means hydroxyl group; X means sulfur atom, sulfinyl or sulfonyl group; Y means oxygen atom; B means purine and/or pyrimidine base under condition that at least one of residues R3 or R5 is hydrogen atom, to their tautomers, their optically active forms and racemic mixtures, or their physiologically acceptable salts of inorganic and organic acids and/or bases and to methods of their synthesis and medicinal agents containing the above mentioned compounds. Compounds of the formula (I) show antitumor activity. EFFECT: new compounds indicated above, improved method of synthesis, valuable antitumor properties. 13 cl, 2 dwg, 4 tbl
Authors
Dates
2001-04-20—Published
1995-05-23—Filed